Recently, Fosun Pharma, Dongcheng Pharmaceutical, Huashen Group and Tianyao Co., Ltd. have slashed their swords, and M&A has integrated many pharmaceutical companies with advantages. Among them, Huashen Group plans to acquire a 51% stake in Wanglintang in cash after a few days of suspension, thereby expanding the company's business scope and improving its profitability. Tianyao shares is planning to spend 1.37 billion yuan to acquire a 62% stake in Jinyao Pharmaceutical and a 100% stake in Hubei Tianyao. At the same time, health news in the field of financing is also frequently heard. According to CVSource data of the financial data products of the China Investment Group, 11 companies including Ping An Doctor, 360 Health and TCM, have announced that they have obtained financing. Among them, O2O health medical service platform Ping An doctor's $500 million A round of financing, refreshed the world's Internet medical start-ups single largest financing and A round of the highest valuation two records. “The emergence of financing and mergers and acquisitions in the medical and health industry is traceable.†Ma Ruiwen, general manager of the CCID Consulting Consumer Products Industry Research Center, said that from a global perspective, the medical and health industry is in a period of rapid development, accompanied by China’s economic level. With continuous improvement, the public's emphasis on medical health has also increased, and China's medical and health industry has entered a period of rapid development. At the same time, China's huge population and the aging of the society have provided a promising market for the medical and health industry, and the popularity of a new generation of information technology and Internet applications is improving the medical level and health management capabilities. It also brings new changes to the health care industry. Statistics show that the current total size of China's medical and health industry is about 4 trillion yuan, and the State Council's "Opinions on Promoting the Development of Health Service Industry" proposes that by 2020, the total scale of China's medical and health industry will exceed 8 trillion yuan. "As far as the current situation is concerned, the active integration of M&A in the medical and health field will not stop." Cai Dajian, chairman of Shenzhen Gaotejia Investment Group Co., Ltd., said that at present, China's medical and health industry is still very fragmented, and the gap between enterprises is also Obviously, some of the dominant companies, including some companies already listed, will become the main force of M&A because their systems have sufficient capital support. For those pharmaceutical companies that aim at IPOs but feel that they are far away, in order to develop, they may choose to cooperate with these powerful enterprises. "Under the role of capital, the speed of mergers and acquisitions and integration of medical and health industries will continue to accelerate. Promote the transformation and upgrading of the industry." Cai Dajian said. Parts Repair Nitrile Gloves,Powder Free Latex Hand Gloves,Exam Gloves Nitrile Powder Free,Nitrile Gloves Medical Powder Free Puyang Linshi Medical Supplies Co., Ltd. , https://www.linshimedicals.com